Acuamark Diagnostics, Inc. Email Format
Biotechnology ResearchNew York, United States2-10 Employees
Acuamark Diagnostics, Inc. is a biotechnology research company based in New York, New York, focused on developing blood-based screening approaches for early cancer detection. Its technology aims to identify cancer markers at initial stages when treatment options are more effective, with the goal of enabling earlier intervention. The firm serves the medical and research community seeking reliable, cost-effective methods for detecting cancer signals in blood, addressing the need for high-precision early detection. Positioned within the biotechnology and diagnostic research landscape, Acuamark Diagnostics emphasizes rigorous scientific expertise to support screening that could supplement existing cancer detection strategies. In recent developments, the company expanded its board with new members, reflecting ongoing strategic governance updates while continuing to pursue its mission in early cancer detection.